TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Juan LiChun-Yang Song

Abstract

Transketolase-like-1 (TKTL1), which is a rate-limiting enzyme in the non-oxidative part of the pentose-phosphate pathway, has been demonstrated to promote carcinogenesis through enhanced aerobic glycolysis. Dysregulation of TKTL1 expression also leads to poor prognosis in patients with urothelial and colorectal cancer. However, the expression pattern and underlying cellular functions in human esophageal squamous cell carcinoma (ESCC) remain largely unexplored. In this study, we measured TKTL1 expression in ESCC cell lines and paraffin-embedded ESCC tumor tissues. Our results revealed that TKTL1 expression was upregulated in all of the four ESCC cell lines and in 61.25% (98/160) of ESCC specimens detected, while only 27.5% (11/40) in normal epithelium. Silencing of TKTL1 expression decreased cell proliferation through inhibiting the expression of MKI67 and cyclins including Ccna2, Ccnb1, Ccnd1 and Ccne1. Meanwhile, down-regulation of TKTL1 also associated with increased apoptotic ratio and altered protein expression of Bcl-2 family in ESCC cells. Furthermore, knockdown of TKTL1 significantly reduced the invasive potential of ESCC cells through up-regulation of anti-metastasis genes (MTSS1, TIMP2 and CTSK) and down-regulation of ...Continue Reading

References

Feb 24, 1956·Science·O WARBURG
Aug 10, 1956·Science·O WARBURG
Sep 14, 2006·Oncology Reports·Wilko I StaigerFrank Willeke
Jul 20, 2007·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Hans-Ullrich VölkerMatthias Eck
Feb 28, 2008·International Journal of Cancer. Journal International Du Cancer·Sigrun LangbeinJohannes F Coy
Jun 14, 2008·American Journal of Clinical Pathology·Hans-Ullrich VölkerCamelia-Maria Monoranu
Aug 14, 2008·Diagnostic Pathology·Holger SchultzTorsten Goldmann
Apr 1, 2009·Journal of Experimental & Clinical Cancer Research : CR·Hui ChenSong Zhang
Jan 15, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Susanne BentzGerhard Rogler
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 27, 2012·Pathology, Research and Practice·Peter FritzGodehard Friedel
Sep 27, 2012·Cancer Discovery·Jason R Cantor, David M Sabatini
Feb 18, 2014·Journal of Cancer Research and Clinical Oncology·Qingxu SongYufeng Cheng
May 17, 2014·World Journal of Gastrointestinal Oncology·Kyle J NapierSubhasis Misra
Jun 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zuxuan ShiQingxia Fan

❮ Previous
Next ❯

Citations

Oct 16, 2019·Oncology Letters·Menghuang ZhaoXueqiong Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.